Skip to main content
Open Access Publications from the University of California


UCLA Previously Published Works bannerUCLA

Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration.

  • Author(s): Fujiwara, Kaori;
  • Inoue, Takuya;
  • Yorifuji, Naoki;
  • Iguchi, Munetaka;
  • Sakanaka, Taisuke;
  • Narabayashi, Ken;
  • Kakimoto, Kazuki;
  • Nouda, Sadaharu;
  • Okada, Toshihiko;
  • Ishida, Kumi;
  • Abe, Yosuke;
  • Masuda, Daisuke;
  • Takeuchi, Toshihisa;
  • Fukunishi, Shinya;
  • Umegaki, Eiji;
  • Akiba, Yasutada;
  • Kaunitz, Jonathan D;
  • Higuchi, Kazuhide
  • et al.

The gut incretin glucagon-like peptide-1 (GLP-1) and the intestinotropic hormone GLP-2 are released from enteroendocrine L cells in response to ingested nutrients. Treatment with an exogenous GLP-2 analogue increases intestinal villous mass and prevents intestinal injury. Since GLP-2 is rapidly degraded by dipeptidyl peptidase 4 (DPP4), DPP4 inhibition may be an effective treatment for intestinal ulcers. We measured mRNA expression and DPP enzymatic activity in intestinal segments. Mucosal DPP activity and GLP concentrations were measured after administration of the DPP4 inhibitor sitagliptin (STG). Small intestinal ulcers were induced by indomethacin (IM) injection. STG was given before IM treatment, or orally administered after IM treatment with or without an elemental diet (ED). DPP4 mRNA expression and enzymatic activity were high in the jejunum and ileum. STG dose-dependently suppressed ileal mucosal enzyme activity. Treatment with STG prior to IM reduced small intestinal ulcer scores. Combined treatment with STG and ED accelerated intestinal ulcer healing, accompanied by increased mucosal GLP-2 concentrations. The reduction of ulcers by ED and STG was reversed by co-administration of the GLP-2 receptor antagonist. DPP4 inhibition combined with luminal nutrients, which up-regulate mucosal concentrations of GLP-2, may be an effective therapy for the treatment of small intestinal ulcers.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View